dcsimg
 
 

Pain

By Tom Steinert-Threlkeld  |  Posted 2003-05-01 Print this article Print
 
 
 
 
 

Endo Pharmaceuticals started out small. But it acted from the beginning as if it would be a billion-dollar company.

-Free in 2002">

Endo Pharmaceuticals: Pain-Free in 2002

Percocet manufacturer Endo Pharmaceuticals worried it might grow so fast, it installed SAP R/3 as its enterprise planning software, from its inception as an offshoot of a Dupont-Merck joint venture. Last year proved the case: The company raised its "guidance" on annual sales for the year three times. And its final estimate was still too low.

  • Sales of Percocet and Lidoderm pain drugs spur first revision of projected revenue.

  • Migration begins to fourth version of SAP customer management software.

  • Cash flow doubles; net loss reduced by 45%.

  • Still on tap: Linking Futurecast sales-forecasting software to SAP.

    Final sales for the year: $399M

    Projection raised one last time

    $380M

    Projection raised again, to $350M

    $285.5M

    Projection raised to $300M at start of Q2...

    $174.9M

    $400M

    Sales projected

    for full year:

    $280M

    300

    200

    100

    $67M

    0

    BASELINE Company's guidance to market on expected sales for the year, before each quarter started.

    ACTUAL Endo's sales, year to date.

    Source: ENDO PHARMACEUTICALS



  • <12345
     
     
     
     
    Editor-in-Chief
    tst@ziffdavisenterprise.com
    Tom was editor-in-chief of Interactive Week, from 1995 to 2000, leading a team that created the Internet industry's first newspaper and won numerous awards for the publication. He also has been an award-winning technology journalist for the Dallas Morning News and Fort Worth Star-Telegram. He is a graduate of the Harvard Business School and the University of Missouri School of Journalism.
     
     
     
     
     
     
     
     
     
     
     

    Submit a Comment

    Loading Comments...
    eWeek eWeek

    Have the latest technology news and resources emailed to you everyday.

    By submitting your information, you agree that baselinemag.com may send you Baselinemag offers via email, phone and text message, as well as email offers about other products and services that Baselinemag believes may be of interest to you. Baselinemag will process your information in accordance with the Quinstreet Privacy Policy.

    Click for a full list of Newsletterssubmit